Summary
Crospon’s drug delivery technology enables painless, controlled intradermal medication delivery of one or more liquid drugs from a single patch applied to the skin. The device is controlled by an on-board microprocessor and is wirelessly programmable. The programmability of the device uniquely enables “programmable pharmacokinetics” whereby the pharmacokinetic profile of the injected drug can be tailored to a particular desired model.
The technology uses microneedles, created on the IMPRESS platform, that penetrate the stratum corneum to create a channel for drug delivery. The microneedles have an extremely sharp tip and reduce the discomfort compared to traditional hypodermic needles. The microneedle geometry enables the delivery system to be worn for extended periods of time as the nerve receptors in the dermis are not stimulated at the resulting shallow penetration depths.
Results type(s)
Unfold all
/
Fold all
More information & hyperlinks
| Country: | UNITED KINGDOM |
| Address: | Crospon - Galway |
Geographical location(s)
Search
Contacts
Associated products/services
- No items published
Organisations
- Not specified